Abstract:BACKGROUND The E3 ubiquitin ligase IDOL (Inducible Degrader of the LDL-Receptor) contributes to regulation of cholesterol metabolism through degradation of LDLR, VLDLR and ApoER2. Human genetic studies support the hypothesis that IDOL could serve as a target for the treatment of dyslipidemia. However, species-specific differences in overall lipid metabolism and IDOL regulation require new preclinical models to realize its therapeutic potential. We leveraged the advantages afforded by the rabbit model to address those limitations and generated a novel rabbit IDOL knockout, which we characterized in the context of atherosclerosis. METHODS IDOL -/- rabbits were generated by CRISPR/ Cas9 technology. IDOL -/- and wildtype littermates, on standard (SD) and atherogenic high-cholesterol diets (HCDs) were compared through assessment of lipid and lipoprotein profiles, triglyceride clearance, lipoprotein lipase (LPL) activity, liver pathology, atherosclerosis development, and fecal cholesterol, with bile acid contents assessed by mass spectrometry. Results Hepatic IDOL expression was increased in response to hypercholesterolemia and hypertriglyceridemia induced by HCD. On SD, loss of IDOL increased LDLR stability with reduced total cholesterol in plasma. On HCD, IDOL -/- rabbits showed simultaneous and remarkable reduction in hypercholesterolemia and hypertriglyceridemia associated with enhanced lipid clearance and LPL activity as well as increased bile acid excretion in feces. IDOL -/- rabbits presented markedly reduced HCD-induced atherosclerosis in the aorta and left coronary artery, without enhanced liver steatosis. CONCLUSIONS Loss of IDOL in rabbits recapitulates human genetic findings, thus setting the stage to accelerate preclinical studies towards development of strategies targeting IDOL for the treatment of atherosclerotic cardiovascular disease. ### Competing Interest Statement The authors have declared no competing interest. * ABCA1 : ATP binding cassette subfamily A member 1 ABCG1 : ATP binding cassette subfamily G member 1 ALT : alanine transaminase ApoER2 : apolipoprotein E receptor 2 AST : aspartate transaminase BW : body weight CETP : cholesteryl ester transfer protein CRISPR : clustered regularly interspaced short palindromic repeats CRP : C-reactive protein CVD : cardiovascular disease DCA : deoxycholic acid FPLC : fast-performance liquid chromatography HCD : high-cholesterol diet HDL : high-density lipoprotein IDL : intermediate-density lipoprotein IDOL : inducible degrader of theLDLR KO : knockout LCA : lithocholic acid LDL : low-density lipoprotein LDLR : LDL receptor LPL : lipoprotein lipase LXR : liver X receptor oxLDL : oxidized low-density lipoprotein qPCR : quantitative real time polymerase chain reaction PCSK9 : proprotein convertase subtilisin/kexin type 9 RXR : retinoid X receptor SD : standard diet SMC : smooth muscle cell SREBP : sterol regulatory element binding transcription factor 2 TC : total cholesterol TG : triglycerides TRL : triglyceride-rich lipoprotein VLDLR : very-low-density lipoprotein receptor WT : wild type

Structural Analysis of the LDL Receptor–interacting FERM Domain in the E3 Ubiquitin Ligase IDOL Reveals an Obscured Substrate-Binding Site

IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer

Inactivation of the E3 Ubiquitin Ligase IDOL Attenuates Diet-Induced Obesity and Metabolic Dysfunction in Mice

IDOL deficiency inhibits cholesterol-rich diet-induced atherosclerosis in rabbits

Intrinsically disordered region amplifies membrane remodeling to augment selective ER-phagy

Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization

Mechanistic insights into the enzymatic activity of E3 ligase HOIL-1L and its regulation by the linear ubiquitin chain binding

Structural insights into the ubiquitylation strategy of the oligomeric CRL2FEM1B E3 ubiquitin ligase

Oligomeric States and Hydrodynamic Properties of Lysyl Oxidase-Like 2

Targeting structural flexibility in low density lipoprotein by integrating cryo-electron microscopy and high-speed atomic force microscopy

Substrate recognition mechanism of the endoplasmic reticulum-associated ubiquitin ligase Doa10

Doa10/MARCH6 architecture interconnects E3 ligase activity with lipid-binding transmembrane channel to regulate SQLE

Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation

Imaging LDL Receptor Oligomerization During Endocytosis Using a Co-Internalization Assay

ERLIN1/2 scaffolds bridge TMUB1 and RNF170 and restrict cholesterol esterification to regulate the secretory pathway

Solution structure of the HOIL-1L NZF domain reveals a conformational switch regulating linear ubiquitin affinity

AlphaFold2 SLiM screen for LC3-LIR interactions in autophagy

Imaging LDL receptor oligomerization during endocytosis using a co-internalization assay.

Structural insights into perilipin 3 membrane association in response to diacylglycerol accumulation